Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry
NCT03231644 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2025-08-12
Summary
The FD/MAS Patient Registry is an IRB-approved research study that that invites the patients and families to help answer some of the biggest questions about FD/MAS by completing questionnaires about their lives with FD or MAS.
Have you enrolled in the FD/MAS Patient Registry yet? Are you up-to-date on your surveys? Take a trip to www.fdmasregistry.org today to learn more about the project, enroll, complete your surveys, or make sure you aren't due to provide more info!
The FD/MAS Patient Registry: Your story powers research.
Conditions
- Fibrous Dysplasia
- McCune Albright Syndrome
- Mazabraud Syndrome
Sponsors & Collaborators
-
Tovah Burstein
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2028-10-31
- Completion
- 2028-10-31
Countries
- United States
Study Locations
More Related Trials
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED
-
Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)
NCT04959188 ·Status: COMPLETED
-
Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
NCT00869479 ·Status: COMPLETED
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa
NCT02323789 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels
NCT01014754 ·Status: COMPLETED
-
Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis
NCT03268330 ·Status: UNKNOWN
-
Stromal Gene Expression During Pulmonary Sarcoidosis
NCT00837668 ·Status: TERMINATED
-
A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa
NCT04599881 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
NCT02579369 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gene First Approach to Connective Tissue Disease
NCT04664478 ·Status: COMPLETED
-
Microvascular and Fibrosis Imaging Study
NCT01758250 ·Status: COMPLETED
-
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
NCT06234384 ·Status: RECRUITING
-
Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15
NCT03893643 ·Status: UNKNOWN
-
Natural History Study of Cutaneous Neurofibromas in People With NF1
NCT05581511 ·Status: ACTIVE_NOT_RECRUITING
-
CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium
NCT01808729 ·Status: COMPLETED
-
Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1
NCT02680431 ·Status: UNKNOWN
-
Scleroderma Registry & Repository at the Hospital for Special Surgery
NCT01656447 ·Status: RECRUITING
-
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
NCT02887495 ·Status: COMPLETED
-
Establishment of the National Epidermolysis Bullosa Registry
NCT00004761 ·Status: COMPLETED
-
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
NCT02777775 ·Status: COMPLETED
-
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
NCT05157958 ·Status: RECRUITING ·Phase: PHASE2
-
Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)
NCT05143190 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnostic Role of Renal Biopsy in Patients With Fabry Disease
NCT06801288 ·Status: COMPLETED
-
Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa
NCT04727268 ·Status: UNKNOWN